These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 21107537)

  • 1. The role of serotonin receptor subtypes in treating depression: a review of animal studies.
    Carr GV; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):265-87. PubMed ID: 21107537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments on Future Antidepressant-related Serotonin Receptors.
    Amidfar M; Kim YK
    Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
    Dias Elpo Zomkowski A; Oscar Rosa A; Lin J; Santos AR; Calixto JB; Lúcia Severo Rodrigues A
    Brain Res; 2004 Oct; 1023(2):253-63. PubMed ID: 15374751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.
    Cryan JF; Valentino RJ; Lucki I
    Neurosci Biobehav Rev; 2005; 29(4-5):547-69. PubMed ID: 15893822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.
    Carr GV; Schechter LE; Lucki I
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):499-507. PubMed ID: 20217056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice.
    Clenet F; De Vos A; Bourin M
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):145-52. PubMed ID: 11313160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors involved in antidepressant effects.
    Artigas F
    Pharmacol Ther; 2013 Jan; 137(1):119-31. PubMed ID: 23022360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?
    Berendsen HH
    Pharmacol Ther; 1995 Apr; 66(1):17-37. PubMed ID: 7630928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data.
    Wesołowska A
    Pharmacol Rep; 2010; 62(4):564-77. PubMed ID: 20884998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.
    Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR
    J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
    Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
    Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM; Monge A; Del Río J; Lasheras B
    Eur J Pharmacol; 2002 May; 442(1-2):63-71. PubMed ID: 12020683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor.
    Shelton J; Bonaventure P; Li X; Yun S; Lovenberg T; Dugovic C
    Neuropharmacology; 2009 Feb; 56(2):448-54. PubMed ID: 18948124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.